Contingency Management in Substance Abuse Treatment
Edited by Stephen T. Higgins, Kenneth Silverman, and Sarah H. Heil
Foreword by Joseph V. Brady
Hardcover
Hardcover
orderSeptember 26, 2007
ISBN 9781593855710
Price: $62.00 380 Pages
Size: 6" x 9"
Sign up for emails on upcoming titles on Addictions (with special discounts)!
Sheila M. Alessi, PhD, Department of Psychiatry, University of Connecticut Health Center, Storrs, Connecticut
Leslie Amass, PhD, Schering Plough Global Medical Affairs, Kenilworth, New Jersey
George E. Bigelow, PhD, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Alan J. Budney, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Kathleen M. Carroll, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Dana A. Cavallo, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Laura Chivers, MA, Department of Psychology, Harvard University, Cambridge, Massachusetts
Jesse Dallery, PhD, Department of Psychology, University of Florida, Gainesville, Florida
Wendy D. Donlin, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Charles Drebing, PhD, New England Mental Illness Research Education and Clinical Center, Bedford VA Medical Center, Bedford, Massachusetts
Amy M. Duhig, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
David H. Epstein, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland
Sarah H. Heil, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont
Stephen T. Higgins, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont
Jonathan B. Kamien, PhD, BioPsych Consulting, Califon, New Jersey
Scott Kellogg, PhD, Department of Psychology, New York University, New York, New York
Todd W. Knealing, PhD, Department of Psychology, Briarcliff University, Sioux City, Iowa
Suchitra Krishnan-Sarin, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Richard J. Lamb, PhD, Departments of Psychiatry and Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
Douglas B. Marlowe, JD, PhD, Treatment Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania
Jesse B. Milby PhD, Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama
Thomas Newton, MD, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
Nancy M. Petry, PhD, Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut
Kenzie L. Preston, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland
Richard K. Ries, MD, Department of Psychiatry and Behavioral Sciences, University of Washington, and Harborview Medical Center, Seattle, Washington
Randall E. Rogers, PhD, Substance Abuse Treatment Center, Burlington, Vermont
John M. Roll, PhD, Washington Institute for Mental Illness Research and Training, Washington State University, Spokane, Washington
Marc Rosen, MD, Department of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut
Robert Rosenheck, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Bruce J. Rounsaville, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Joseph Schumacher, PhD, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama
Stacey C. Sigmon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont
Kenneth Silverman, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Catherine Stanger, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Maxine L. Stitzer, PhD, Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland
Jennifer W. Tidey, PhD, Center for Alcohol and Addiction Studies, and Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island
Conrad J. Wong, PhD, Department of Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky
Jin H. Yoon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont
Leslie Amass, PhD, Schering Plough Global Medical Affairs, Kenilworth, New Jersey
George E. Bigelow, PhD, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Alan J. Budney, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Kathleen M. Carroll, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Dana A. Cavallo, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Laura Chivers, MA, Department of Psychology, Harvard University, Cambridge, Massachusetts
Jesse Dallery, PhD, Department of Psychology, University of Florida, Gainesville, Florida
Wendy D. Donlin, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Charles Drebing, PhD, New England Mental Illness Research Education and Clinical Center, Bedford VA Medical Center, Bedford, Massachusetts
Amy M. Duhig, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
David H. Epstein, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland
Sarah H. Heil, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont
Stephen T. Higgins, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont
Jonathan B. Kamien, PhD, BioPsych Consulting, Califon, New Jersey
Scott Kellogg, PhD, Department of Psychology, New York University, New York, New York
Todd W. Knealing, PhD, Department of Psychology, Briarcliff University, Sioux City, Iowa
Suchitra Krishnan-Sarin, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Richard J. Lamb, PhD, Departments of Psychiatry and Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
Douglas B. Marlowe, JD, PhD, Treatment Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania
Jesse B. Milby PhD, Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama
Thomas Newton, MD, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
Nancy M. Petry, PhD, Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut
Kenzie L. Preston, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland
Richard K. Ries, MD, Department of Psychiatry and Behavioral Sciences, University of Washington, and Harborview Medical Center, Seattle, Washington
Randall E. Rogers, PhD, Substance Abuse Treatment Center, Burlington, Vermont
John M. Roll, PhD, Washington Institute for Mental Illness Research and Training, Washington State University, Spokane, Washington
Marc Rosen, MD, Department of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut
Robert Rosenheck, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Bruce J. Rounsaville, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Joseph Schumacher, PhD, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama
Stacey C. Sigmon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont
Kenneth Silverman, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Catherine Stanger, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Maxine L. Stitzer, PhD, Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland
Jennifer W. Tidey, PhD, Center for Alcohol and Addiction Studies, and Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island
Conrad J. Wong, PhD, Department of Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky
Jin H. Yoon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont